+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac AI Monitoring and Diagnostics Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • April 2024
  • Region: Global
  • The Business Research Company
  • ID: 5951919
The cardiac AI monitoring and diagnostics market size has grown exponentially in recent years. It will grow from $1.35 billion in 2023 to $1.71 billion in 2024 at a compound annual growth rate (CAGR) of 26.6%. The growth observed in the historical period can be attributed to various factors, including demographic changes with an aging population, an increase in remote patient monitoring solutions, higher healthcare expenditure, the execution of clinical research and validation studies, and a heightened focus on preventive healthcare measures.

The cardiac AI monitoring and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $4.37 billion in 2028 at a compound annual growth rate (CAGR) of 26.4%. The anticipated growth in the forecast period can be attributed to various factors, including the expansion of wearable and IoT (Internet of Things) devices, an increasing adoption of telemedicine and remote monitoring solutions, integration of big data analytics and predictive modeling in cardiac care, a focus on patient-centered care and remote patient engagement initiatives, and ongoing healthcare infrastructure development. Key trends expected in the forecast period encompass the integration of AI with wearable devices, personalized risk assessment and treatment planning leveraging AI capabilities, the use of predictive analytics for forecasting cardiovascular events, integration of multimodal data sources for comprehensive analysis, and the emphasis on interoperability and data integration standards within the healthcare ecosystem.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the cardiac AI monitoring and diagnostics market in the foreseeable future. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, stroke, and heart failure. Cardiac AI monitoring and diagnostics play a crucial role in the early detection, risk assessment, and personalized treatment of these conditions, ultimately leading to improved patient outcomes. For instance, data from the Centers for Disease Control and Prevention (CDC) in May 2023 revealed a concerning rise in the number of deaths attributed to heart disease in the United States, underlining the pressing need for advanced cardiac monitoring and diagnostic solutions.

Leading companies operating in the cardiac AI monitoring and diagnostics market are directing their efforts towards the development of technology-driven medical devices, such as artificial intelligence-based implantable cardiac monitors, to solidify their position in the market. Artificial intelligence-based implantable cardiac monitors represent a groundbreaking innovation in cardiovascular healthcare, offering continuous and accurate monitoring of cardiac function. For example, in May 2023, Biotronik, a renowned cardiovascular biomedical research and technology company based in Germany, announced the FDA approval of its BIOMONITOR IV implantable cardiac monitor (ICM). Equipped with BIOTRONIK's cutting-edge SmartECG algorithm powered by artificial intelligence, the BIOMONITOR IV ICM sets a new standard in cardiac monitoring accuracy. By leveraging advanced algorithms, the SmartECG technology significantly reduces false identifications while maintaining a high detection rate for genuine cardiac episodes. This enhancement in detection accuracy empowers healthcare professionals to make prompt and precise diagnoses, thus optimizing patient care and outcomes. Furthermore, the BIOMONITOR IV ICM distinguishes between different types of cardiac contractions, such as premature ventricular contractions (PVCs) and premature atrial contractions (PACs), further enhancing its diagnostic capabilities and clinical utility.

In January 2022, Koninklijke Philips N.V., a healthcare technology company headquartered in the Netherlands, completed the acquisition of Cardiologs Technologies SAS, a medical technology company based in France, for an undisclosed sum. This strategic move positions Cardiologs to enhance Philips' cardiac monitoring and diagnostics portfolio through the integration of innovative software solutions, electrocardiogram (ECG) analysis, and reporting services. Cardiologs Technologies SAS specializes in optimizing cardiac diagnostics through the utilization of artificial intelligence (AI) and cloud technologies, aligning with Philips' commitment to advancing healthcare through cutting-edge innovations.

Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac ai monitoring and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cardiac AI monitoring and diagnostics involve the application of artificial intelligence (AI) technologies in the field of cardiology to monitor and diagnose various cardiovascular conditions. This utilizes advanced algorithms and machine learning techniques to analyze data from cardiac monitoring devices, such as electrocardiograms (ECGs).

The main categories of cardiac AI monitoring and diagnostics are cardiac diagnostics and cardiac monitoring. Cardiac diagnostics encompass methods and procedures used to identify heart conditions associated with unhealthy or pathologic heart function. The products in this category include software and hardware used in applications such as ischemic heart diseases or coronary artery disease (CAD), cardiac arrhythmias, ischemic stroke, and others. End users of these cardiac AI solutions include hospitals, diagnostic centers, and various healthcare facilities.

The cardiac AI monitoring and diagnostics research report is one of a series of new reports that provides cardiac AI monitoring and diagnostics market statistics, including the cardiac AI monitoring and diagnostics industry's global market size, regional shares, competitors with an cardiac AI monitoring and diagnostics market share, detailed cardiac AI monitoring and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac AI monitoring and diagnostics industry. This cardiac AI monitoring and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac AI monitoring and diagnostics market consists of revenues earned by entities by providing services such as ST-segment monitoring, arrhythmia detection, heart rate variability analysis, risk stratification, and echocardiogram interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac AI monitoring and diagnostics market also includes sales of echocardiography devices, cardiac MRI and CT analysis, electrocardiogram (ECG) analysis tools, and wearable devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Cardiac AI Monitoring And Diagnostics Market Characteristics3. Cardiac AI Monitoring And Diagnostics Market Trends And Strategies
4. Cardiac AI Monitoring And Diagnostics Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Cardiac AI Monitoring And Diagnostics Market Size and Growth
5.1. Global Cardiac AI Monitoring And Diagnostics Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Cardiac AI Monitoring And Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cardiac AI Monitoring And Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Cardiac AI Monitoring And Diagnostics Market Segmentation
6.1. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiac Diagnostics
  • Cardiac Monitoring
6.2. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Software
  • Hardware
6.3. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ischemic Heart Diseases Or Coronary Artery Disease (CAD)
  • Cardiac Arrhythmias
  • Ischemic Stroke
  • Other Applications
6.4. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Other End Users
7. Cardiac AI Monitoring And Diagnostics Market Regional And Country Analysis
7.1. Global Cardiac AI Monitoring And Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cardiac AI Monitoring And Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market
8.1. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market Overview
(Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies)
8.2. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Cardiac AI Monitoring And Diagnostics Market
9.1. China Cardiac AI Monitoring And Diagnostics Market Overview
9.2. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Cardiac AI Monitoring And Diagnostics Market
10.1. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Cardiac AI Monitoring And Diagnostics Market
11.1. Japan Cardiac AI Monitoring And Diagnostics Market Overview
11.2. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Cardiac AI Monitoring And Diagnostics Market
12.1. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Cardiac AI Monitoring And Diagnostics Market
13.1. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Cardiac AI Monitoring And Diagnostics Market
14.1. South Korea Cardiac AI Monitoring And Diagnostics Market Overview
14.2. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Cardiac AI Monitoring And Diagnostics Market
15.1. Western Europe Cardiac AI Monitoring And Diagnostics Market Overview
15.2. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Cardiac AI Monitoring And Diagnostics Market
16.1. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Cardiac AI Monitoring And Diagnostics Market
17.1. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Cardiac AI Monitoring And Diagnostics Market
18.1. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Cardiac AI Monitoring And Diagnostics Market
19.1. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Cardiac AI Monitoring And Diagnostics Market
20.1. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Cardiac AI Monitoring And Diagnostics Market
21.1. Eastern Europe Cardiac AI Monitoring And Diagnostics Market Overview
21.2. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Cardiac AI Monitoring And Diagnostics Market
22.1. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Cardiac AI Monitoring And Diagnostics Market
23.1. North America Cardiac AI Monitoring And Diagnostics Market Overview
23.2. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Cardiac AI Monitoring And Diagnostics Market
24.1. USA Cardiac AI Monitoring And Diagnostics Market Overview
24.2. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Cardiac AI Monitoring And Diagnostics Market
25.1. Canada Cardiac AI Monitoring And Diagnostics Market Overview
25.2. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Cardiac AI Monitoring And Diagnostics Market
26.1. South America Cardiac AI Monitoring And Diagnostics Market Overview
26.2. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Cardiac AI Monitoring And Diagnostics Market
27.1. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Cardiac AI Monitoring And Diagnostics Market
28.1. Middle East Cardiac AI Monitoring And Diagnostics Market Overview
28.2. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Cardiac AI Monitoring And Diagnostics Market
29.1. Africa Cardiac AI Monitoring And Diagnostics Market Overview
29.2. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape And Company Profiles
30.1. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape
30.2. Cardiac AI Monitoring And Diagnostics Market Company Profiles
30.2.1. Abbott Laboratories
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Medtronic plc
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Siemens Healthineers AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Koninklijke Philips N.V.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. GE HealthCare Technologies Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Cardiac AI Monitoring And Diagnostics Market Other Major And Innovative Companies
31.1. Boston Scientific Corporation
31.2. ZOLL Medical Corporation
31.3. Canon Medical Systems Corporation
31.4. Biotronik SE & Co. KG
31.5. iRhythm Technologies Inc.
31.6. Tempus Labs Inc.
31.7. Viz.ai Inc.
31.8. HeartFlow Inc.
31.9. Aidoc
31.10. Eko Devices Inc.
31.11. CardioFocus Inc.
31.12. Circle Cardiovascular Imaging Inc.
31.13. Ultromics Limited.
31.14. Cathworks
31.15. Medicalgorithmics S.A.
32. Global Cardiac AI Monitoring And Diagnostics Market Competitive Benchmarking33. Global Cardiac AI Monitoring And Diagnostics Market Competitive Dashboard34. Key Mergers And Acquisitions In The Cardiac AI Monitoring And Diagnostics Market
35. Cardiac AI Monitoring And Diagnostics Market Future Outlook and Potential Analysis
35.1 Cardiac AI Monitoring And Diagnostics Market In 2028 - Countries Offering Most New Opportunities
35.2 Cardiac AI Monitoring And Diagnostics Market In 2028 - Segments Offering Most New Opportunities
35.3 Cardiac AI Monitoring And Diagnostics Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright And Disclaimer

Executive Summary

Cardiac AI Monitoring And Diagnostics Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac AI monitoring and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for cardiac AI monitoring and diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac AI monitoring and diagnostics market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Cardiac Diagnostics; Cardiac Monitoring
2) By Product: Software; Hardware
3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD); Cardiac Arrhythmias; Ischemic Stroke; Other Applications.
4) By End Users: Hospitals; Diagnostic Centers; Other End Users

Key Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Abbott Laboratories
  • Medtronic plc
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Boston Scientific Corporation
  • ZOLL Medical Corporation
  • Canon Medical Systems Corporation
  • Biotronik SE & Co. KG
  • iRhythm Technologies Inc.
  • Tempus Labs Inc.
  • Viz.ai Inc.
  • HeartFlow Inc.
  • Aidoc
  • Eko Devices Inc.
  • CardioFocus Inc.
  • Circle Cardiovascular Imaging Inc.
  • Ultromics Limited.
  • Cathworks
  • Medicalgorithmics S.A.
  • Nanox.AI Ltd
  • Cardiac Insight Inc.
  • CardioSecur GmbH
  • Cardionomic Inc.
  • HeartSciences
  • CardioComm Solutions Inc.
  • CardioDiagnostics Inc.

Methodology

Loading
LOADING...

Table Information